Markus Gershater (@markusgershater) 's Twitter Profile
Markus Gershater

@markusgershater

Biologist who aspires to engineer. CSO & cofounder @synthace

ID: 163830756

linkhttp://www.synthace.com calendar_today07-07-2010 11:32:15

1,1K Tweet

1,1K Followers

1,1K Following

Tom Ellis (@proftomellis) 's Twitter Profile Photo

The most Craig Venter thing ever is Craig Venter retweeting a Russian gov doc that describes Craig Venter as “going towards a role of a god”.

The most Craig Venter thing ever is Craig Venter retweeting a Russian gov doc that describes Craig Venter as “going towards a role of a god”.
Sabina Leonelli (@sabinaleonelli) 's Twitter Profile Photo

Great to see philosophical work on data, metadata & experimentation (incl. Hans Radder’s seminal work), and “data journeys” as explored in European Research Council (ERC) project #DATA SCIENCE, inform the development of intelligent #AI for #biology! Uni of Exeter's Institute for Data Science and AI The Alan Turing Institute #HPS

Cell and Gene Therapy Catapult (@cgtcatapult) 's Twitter Profile Photo

Don't miss our next CGTC Morning Tips webinar to learn how #automation can be used to overcome #ATMP analysis bottlenecks, with special guest speaker Markus Gershater, Co-Founder & CSO Synthace! Wednesday 9 June, 09:00-09:30 BST Register for free! 👉 ow.ly/VuK250EQaM1

Don't miss our next CGTC Morning Tips webinar to learn how #automation can be used to overcome #ATMP analysis bottlenecks, with special guest speaker Markus Gershater, Co-Founder &amp; CSO <a href="/synthace/">Synthace</a>! 

Wednesday 9 June, 09:00-09:30 BST
Register for free! 👉 ow.ly/VuK250EQaM1
Synthace (@synthace) 's Twitter Profile Photo

Has the astounding pace of the COVID #vaccine development set a new expectation for the #therapeutics industry? Our CSO Markus Gershater discusses if we've arrived at a new normal & how we need to apply our learnings to future #DrugDiscovery & development👉synthace.com/covid-vaccine-…

Has the astounding pace of the COVID #vaccine development set a new expectation for the #therapeutics industry? Our CSO <a href="/markusgershater/">Markus Gershater</a> discusses if we've arrived at a new normal &amp; how we need to apply our learnings to future #DrugDiscovery &amp; development👉synthace.com/covid-vaccine-…
Synthace (@synthace) 's Twitter Profile Photo

Has the astounding pace of the COVID #vaccine development set a new expectation for the #therapeutics industry? Our CSO Markus Gershater discusses if we've arrived at a new normal & how we need to apply our learnings to future #DrugDiscovery & development👉synthace.com/covid-vaccine-…

Synthace (@synthace) 's Twitter Profile Photo

#ICYMI: Today we announced our new Synthace Life Sciences R&D Cloud, the first ever no-code platform that lowers the barriers to automated biological experimentation and insight sharing. Read the press release to learn more👉synthace.com/synthace-unvei… #LifeSciences #CloudComputing

#ICYMI: Today we announced our new Synthace Life Sciences R&amp;D Cloud, the first ever no-code platform that lowers the barriers to automated biological experimentation and insight sharing. Read the press release to learn more👉synthace.com/synthace-unvei…

#LifeSciences #CloudComputing
Synthace (@synthace) 's Twitter Profile Photo

Excited to announce in scwmagazine! Check out the post to find out all about our #NoCode cloud platform for #LifeSciences R&D, with insights from our CEO Guy Levy-Yurista. More here👉scientific-computing.com/news/synthace-… #CloudComputing #LabOfTheFuture

Excited to announce in <a href="/scwmagazine/">scwmagazine</a>! Check out the post to find out all about our #NoCode cloud platform for #LifeSciences R&amp;D, with insights from our CEO <a href="/GuyLevyYurista/">Guy Levy-Yurista</a>. More here👉scientific-computing.com/news/synthace-…

#CloudComputing #LabOfTheFuture
Guy Levy-Yurista (@guylevyyurista) 's Twitter Profile Photo

Dare to envision limitless science Experiment truly consistently, everywhere Transform your Life Science R&D synthace.com/synthace-unvei…

Synthace (@synthace) 's Twitter Profile Photo

"We really need to #digitize & move research to the #cloud to set science free & allow everyone to interact with it everywhere," Guy Levy-Yurista, CEO of Synthace, told Forbes. Read on to learn more about how our platform is transforming #LifeSciences R&D👉forbes.com/sites/johncumb…

SynBioBeta (@synbiobeta) 's Twitter Profile Photo

.Synthace announced the first #LifeSciences research and development (R&D) #cloud that includes no-code software. By making collaboration and automation easier, Synthace is lowering #accessibility barriers for science. ow.ly/hnvI50FPjWI Guy Levy-Yurista Markus Gershater

Demis Hassabis (@demishassabis) 's Twitter Profile Photo

Thrilled to announce the launch of a new Alphabet company Isomorphic Labs. Our mission is to reimagine the drug discovery process from first principles with an AI-first approach, to accelerate biomedical breakthroughs and find cures for diseases. Details: isomorphiclabs.com/blog

Thrilled to announce the launch of a new Alphabet company <a href="/IsomorphicLabs/">Isomorphic Labs</a>. Our mission is to reimagine the drug discovery process from first principles with an AI-first approach, to accelerate biomedical breakthroughs and find cures for diseases. Details: isomorphiclabs.com/blog
Synthace (@synthace) 's Twitter Profile Photo

Exciting News! We've closed our $35M Series C funding led by @Sofinnovavc and Horizons Ventures 🎉 Thanks to our customers, partners, investors, and our amazing team for continuing our Life Sciences R&D cloud mission! ♥️🌍 ➡️ Read Synthace’s story here: hubs.la/H0_hMJL0